Skip to content

Clinical trials

Phase 1/2 Esophageal Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20161
20171
20181
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Amgen1
Centre Hospitalier Universitaire de Besancon1
Federation Francophone de Cancerologie Digestive1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Gustave Roussy, Cancer Campus, Grand Paris1
Marengo Therapeutics, Inc.1
Merus B.V.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms11
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Lung Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Biliary Tract Neoplasms2
Endometrial Neoplasms2
Esophageal Squamous Cell Carcinoma2
Gastrointestinal Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.